Use this table as a quick map, then read each full review below for the lab data and the one caveat that matters most
Abbreviations AE: Adverse event DAEN: Australian Database of Adverse Event Notifications DPP4is: Dipeptidyl peptidase 4 inhibitors FAERS: The FDA Adverse Event Reporting System GLP1-RAs: Glucagon-like peptide 1 receptor agonists IC: Information component PRR: Proportional reporting ratio PT: Preferred terms ROR: Reporting odds ratio RRR: Relative reporting ratio SGLT2is: Sodium-glucose transporter 2 inhibitors References Lee YS, Jun HS
Clinical evidence indicates that dual users have significantly greater odds of developing metabolic syndrome, elevated triglyceride levels, and reduced HDL-cholesterol compared to never smokers [136]
[7] Semaglutide, under the brand name Wegovy, is approved for chronic weight management in people with a BMI of 27 or higher with at least one weight-related condition or in people with a BMI of 30 or higher
Mental health conditions including depression, anxiety, and binge eating disorder commonly coexist with obesity